Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / HRTX - Heron Therapeutics Q3 2021 Earnings Preview


HRTX - Heron Therapeutics Q3 2021 Earnings Preview

Heron Therapeutics (NASDAQ:HRTX) is scheduled to announce Q3 earnings results on Wednesday, November 3rd, after market close. The consensus EPS Estimate is -$0.60 and the consensus Revenue Estimate is $25.51M (+27.7% Y/Y). In October, Seeking Alpha contributor Biologics believes that the company's Zynrelef treatment might struggle in its first few quarters on the market. Heron posted second-quarter revenue and profit that missed Wall Street estimates, and provided an update on its cash position, in August. Over the last 3 months, EPS estimates have seen 0 upward revisions and 3 downward. Revenue estimates have seen 0 upward revisions and 5 downward. The company's shares have fallen more than 46% year to date.

For further details see:

Heron Therapeutics Q3 2021 Earnings Preview
Stock Information

Company Name: Heron Therapeutics Inc.
Stock Symbol: HRTX
Market: NASDAQ
Website: herontx.com

Menu

HRTX HRTX Quote HRTX Short HRTX News HRTX Articles HRTX Message Board
Get HRTX Alerts

News, Short Squeeze, Breakout and More Instantly...